OBJECTIVES Factors contributing to the development of systemic lupus erythematosus (SLE) remain largely unknown although are likely to include both environmental and genetic components. Studies on murine lupus have indicated a role for an antibody that blocks binding of cytotoxic T lymphocyte associated-4 (CTLA-4) to B7 on antigen presenting cells in the treatment of disease, suggesting that CTLA-4 may play an important part in the disease process. This study, therefore, investigated the frequency of a previously described A-G polymorphism in exon 1 of theCTLA-4 gene, the G allele of which has shown to be associated with both Graves’ disease and type I diabetes, to determine whether this polymorphism was playing a part in the development of SLE.
METHODS One hundred and twenty six SLE patients and 363 control subjects were genotyped for the A-G polymorphism in exon 1 of theCTLA-4 gene. Target DNA was amplified using the polymerase chain reaction and the resulting product was digested using the BbvI restriction enzyme.
RESULTS No differences in allele or genotype frequencies were observed between patients with SLE and control subjects.
CONCLUSION These data suggest that the A-G polymorphism in exon 1 of theCTLA-4 gene does not play a part in the genetic susceptibility to the development of SLE.
- systemic lupus erythematosus
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.